Par Drugs and Chemicals Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 229.35 million compared to INR 235.07 million a year ago. Revenue was INR 229.47 million compared to INR 236.6 million a year ago.

Net income was INR 24.68 million compared to INR 22.94 million a year ago. Basic earnings per share from continuing operations was INR 2.01 compared to INR 1.86 a year ago. Diluted earnings per share from continuing operations was INR 2.01 compared to INR 1.86 a year ago.